Depends on the FDA's Dr. Scott Gottlieb and what additional information he is looking for. Once the trial begins, if interim results of 6 months for the Phase 3 are similar to the Phase 2B the FDA could award the Commercial BLA at that time. Otherwise could be 1 year results or as long as 2 years. It all depends on the FDA. The Phase2B results for the 114 persons enrollment were great which would be what needs to be demonstrated in the larger Phase 3.